Two more sites were used as controls: one within the prion gene (PRNP) and another within ANK1, a gene whose hypermethylation has consistently been reported in Alzheimer’s disease (AD) [33]. The gene discussed is PRNP; the disease is early-onset autosomal dominant Alzheimer disease.